---
layout: layout-team.njk
member: Prof. Stefan Leucht, MD
title: Section Head, EBMPP
mail: stefan.leucht@tum.de
photo: "/assets/members/stefan-leucht.jpg"
orcidLink: "https://orcid.org/0000-0002-4934-4352"
scholarLink: "https://scholar.google.com/citations?user=9K3vBQ4AAAAJ&hl=en&oi=ao"
permalink: "/team/prof-stefan-leucht/"
---

<br>

[Stefan Leucht: a (meta)analysis of his life (_Lancet Psychiatry_) ↗](/assets/docs/lancet.pdf)

<br>

The overarching theme of Dr. Leucht's research is **evidence-based medicine in psychiatry**, with a focus on **meta-analyses, clinical trials**, and improving study methodologies in psychiatry. He also has a research interest in **shared decision-making** and **pharmacogenetics**.

<br>

### Biography
---

Stefan Leucht studied medicine in Germany, South Africa, Spain, and the USA. He is the head of the **Section of Evidence-Based Medicine in Psychiatry and Psychotherapy** at the **Technical University of Munich**, Germany, where he has practiced since **1994**.

He worked as a research associate at the **Zucker Hillside Hospital** in New York during 2002/2003, spent a year as an honorary fellow at the University Department of Psychiatry in Oxford, and held a position as honorary professor of Evidence-based Psychopharmacology at the **University of Aarhus, Denmark** until 2019. Currently, he is a **visiting professor** at the **Institute of Psychiatry, King’s College London**, and at **Shanghai Jiao Tong University School of Medicine**.

<br>

### Editorial Roles
---

Professor Leucht is part of the editorial teams of several psychiatric journals, including:

- Cochrane Schizophrenia Group
- Lancet Psychiatry
- Schizophrenia Research
- Schizophrenia Bulletin
- Acta Psychiatrica Scandinavica
- International Clinical Psychopharmacology
- European Neuropsychopharmacology
- European Psychiatry

<br>

### Impact & Awards
---

Since the **inception of the ranking in 2014**, **Thompson Reuters** has named Stefan Leucht as a **Highly Cited Researcher**. In 2021, [Expertscape](http://expertscape.com/ex/schizophrenia) ranked him among the **top ten schizophrenia researchers**. He led the **schizophrenia guideline group** of the **College of International Neuropsychopharmacology (CINP)**.

He has received several awards, including the:

- David Sackett Award of the German Network of Evidence-Based Medicine (2010)
- American Psychiatric Association Young Minds in Psychiatry Award (2004)
- Robert Kerwin Award of the Royal College of Psychiatry (2012).

